期刊
SURVEY OF OPHTHALMOLOGY
卷 63, 期 5, 页码 618-637出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.survophthal.2018.04.002
关键词
pediatric ophthalmology; preterm infant; retina; retinopathy of prematurity; risk factor; risk model
资金
- National Institutes of Health (Bethesda, MD) [R01EY19474, T32EY23211, P30EY10572]
- National Science Foundation (Arlington, VA) [SCH-1622679]
- Research to Prevent Blindness (New York, NY)
Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature infants. Despite improvements in neonatal care and management guidelines, ROP remains a leading cause of childhood blindness worldwide. Current screening guidelines are primarily based on two risk factors: birth weight and gestational age; however, many investigators have suggested other risk factors, including maternal factors, prenatal and perinatal factors, demographics, medical interventions, comorbidities of prematurity, nutrition, and genetic factors. We review the existing literature addressing various possible ROP risk factors. Although there have been contradictory reports, and the risk may vary between different populations, understanding ROP risk factors is essential to develop predictive models, to gain insights into pathophysiology of retinal vascular diseases and diseases of prematurity, and to determine future directions in management of and research in ROP. (C) 2018 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据